Every healthcare system tracks cardiovascular outcomes. Few treat cholesterol management as a leadership-level design question. Dyslipidemia sits quietly in lab reports across primary care, cardiology, endocrinology, and internal medicine. It is common. It is measurable. It is modifiable. And it is expensive when poorly controlled. More than one third of Americans have elevated LDL cholesterol....Read More